EGFR overexpression has been extensively studied due to its involvement in the development of lethal cancers, including non-small-cell lung cancer (NSCLC), and head-and-neck, breast, colon, and ovarian cancer [16,17]. Here, EGFR is linked to ovarian carcinoma.